Endothelial Leakiness Induced by Amyloid Protein Aggregation

Alzheimer’s disease (AD) is a major cause of dementia debilitating the global ageing population. Current understanding of the AD pathophysiology implicates the aggregation of amyloid beta (Aβ) as causative to neurodegeneration, with tauopathies and neuroinflammation considered as other major culprits. Curiously, vascular endothelial barrier dysfunction is strongly associated with Aβ deposition and 80-90% AD subjects also experience cerebral amyloid angiopathy. Here we show amyloid proteins-induced endothelial leakiness (APEL) in human microvascular endothelial monolayers as well as in mouse cerebral vasculature. Using signaling pathway assays and discrete molecular dynamics, we revealed that the angiopathy first arose from a disruption to vascular endothelial (VE)-cadherin junctions exposed to the nanoparticulates of Aβ oligomers and seeds, preceding the earlier implicated proinflammatory and pro-oxidative stressors to endothelial leakiness. These findings are analogous to nanomaterials-induced endothelial leakiness (NanoEL), a major phenomenon in nanomedicine depicting the paracellular transport of anionic inorganic nanoparticles in the vasculature. As APEL also occurred with the anionic seeds of pathogenic alpha synuclein and functional FapC bacterial amyloid, this study projects a general new paradigm for elucidating the vascular permeation, systemic spread, and cross-seeding of amyloid proteins that underlie the pathogeneses of AD, Parkinson’s, as well as a range of amyloid diseases.

[1]  D. Leong,et al.  A Framework of Paracellular Transport via Nanoparticles‐Induced Endothelial Leakiness , 2021, Advanced science.

[2]  P. Ke,et al.  Inhibition of Amyloid Aggregation and Toxicity with Janus Iron Oxide Nanoparticles. , 2021, Chemistry of materials : a publication of the American Chemical Society.

[3]  C. Parish,et al.  Spontaneous Formation of β-sheet Nano-barrels during the Early Aggregation of Alzheimer's Amyloid Beta. , 2021, Nano today.

[4]  F. Ding,et al.  Probing interdomain linkers and protein supertertiary structure in vitro and in live cells with fluorescent protein resonance energy transfer. , 2020, Journal of molecular biology.

[5]  D. Eisenberg,et al.  Half a century of amyloids: past, present and future. , 2020, Chemical Society reviews.

[6]  S. Yonehara,et al.  Molecular Mechanism of Apoptosis by Amyloid β-Protein Fibrils Formed on Neuronal Cells. , 2020, ACS chemical neuroscience.

[7]  J. Klohs.  An Integrated View on Vascular Dysfunction in Alzheimer’s Disease , 2020, Neurodegenerative Diseases.

[8]  Tobias C. Wood,et al.  Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease , 2019, Molecular Psychiatry.

[9]  Arun Prasath,et al.  Nanoparticles' interactions with vasculature in diseases. , 2019, Chemical Society reviews.

[10]  D. Holtzman,et al.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.

[11]  C. Parish,et al.  Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy , 2019, Nature Communications.

[12]  A. Saykin,et al.  Blood-based biomarkers for Alzheimer ’ s disease and related dementias Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition , 2019 .

[13]  A. Purcell,et al.  Amyloid Self-Assembly of hIAPP8-20 via the Accumulation of Helical Oligomers, α-Helix to β-Sheet Transition, and Formation of β-Barrel Intermediates. , 2019, Small.

[14]  M. I. Setyawati,et al.  Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness , 2019, Nature Nanotechnology.

[15]  Chuanlu Jiang,et al.  Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of β-Amyloid Aggregates in Alzheimer's Disease Mice. , 2018, Nano letters.

[16]  Feng Ding,et al.  Identifying weak interdomain interactions that stabilize the supertertiary structure of the N-terminal tandem PDZ domains of PSD-95 , 2018, Nature Communications.

[17]  Feng Ding,et al.  β-barrel Oligomers as Common Intermediates of Peptides Self-Assembling into Cross-β Aggregates , 2018, Scientific Reports.

[18]  D. Attwell,et al.  Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes , 2019, Science.

[19]  Yao-Xin Lin,et al.  A self-destructive nanosweeper that captures and clears amyloid β-peptides , 2018, Nature Communications.

[20]  Myung Chul Choi,et al.  Inhibition of Human Amylin Aggregation and Cellular Toxicity by Lipoic Acid and Ascorbic Acid. , 2018, Molecular pharmaceutics.

[21]  M. Kinjo,et al.  Not Oligomers but Amyloids are Cytotoxic in the Membrane‐Mediated Amyloidogenesis of Amyloid‐β Peptides , 2018, Chembiochem : a European journal of chemical biology.

[22]  Hong Zhang,et al.  Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer's Disease. , 2018, ACS nano.

[23]  R. Mezzenga,et al.  Implications of peptide assemblies in amyloid diseases. , 2017, Chemical Society reviews.

[24]  Feng Ding,et al.  Distinct oligomerization and fibrillization dynamics of amyloid core sequences of amyloid-beta and islet amyloid polypeptide. , 2017, Physical chemistry chemical physics : PCCP.

[25]  G. Schröder,et al.  Fibril structure of amyloid-β(1–42) by cryo–electron microscopy , 2017, Science.

[26]  Hong-li Wu,et al.  Amyloid β-42 induces neuronal apoptosis by targeting mitochondria , 2017, Molecular medicine reports.

[27]  Chor Yong Tay,et al.  Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin. , 2017, ACS nano.

[28]  M. I. Setyawati,et al.  Nanoparticle Density: A Critical Biophysical Regulator of Endothelial Permeability. , 2017, ACS nano.

[29]  Ding-I Yang,et al.  Hyperglycemia Increases the Production of Amyloid Beta‐Peptide Leading to Decreased Endothelial Tight Junction , 2016, CNS neuroscience & therapeutics.

[30]  M. I. Setyawati,et al.  Tuning Endothelial Permeability with Functionalized Nanodiamonds. , 2016, ACS nano.

[31]  D. Raleigh,et al.  Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology , 2015, Journal of diabetes research.

[32]  D. Walsh,et al.  Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier , 2015, Science Advances.

[33]  B. Kalionis,et al.  Aβ1–42 oligomer‐induced leakage in an in vitro blood–brain barrier model is associated with up‐regulation of RAGE and metalloproteinases, and down‐regulation of tight junction scaffold proteins , 2015, Journal of neurochemistry.

[34]  S. Askarova,et al.  Role of ROS in Aβ42 Mediated Activation of Cerebral Endothelial Cells , 2014, Central Asian journal of global health.

[35]  H. Schnittler,et al.  Actin filament dynamics and endothelial cell junctions: the Ying and Yang between stabilization and motion , 2014, Cell and Tissue Research.

[36]  Bin Zhang,et al.  Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons , 2013, Cell.

[37]  Say Chye Joachim Loo,et al.  Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin , 2013, Nature Communications.

[38]  C. Griesinger,et al.  Bioinorganic chemistry of copper coordination to alpha-synuclein: Relevance to Parkinson's disease , 2012 .

[39]  C. Ha,et al.  Aβ1–42-RAGE Interaction Disrupts Tight Junctions of the Blood–Brain Barrier Via Ca2+-Calcineurin Signaling , 2012, The Journal of Neuroscience.

[40]  J. Ghiso,et al.  Insights into Caspase-Mediated Apoptotic Pathways Induced by Amyloid-β in Cerebral Microvascular Endothelial Cells , 2011, Neurodegenerative Diseases.

[41]  H. D. de Vries,et al.  Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. , 2011, Antioxidants & redox signaling.

[42]  B. Honig,et al.  Structure and binding mechanism of vascular endothelial cadherin: a divergent classical cadherin. , 2011, Journal of molecular biology.

[43]  G. V. Chaitanya,et al.  PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration , 2010, Cell Communication and Signaling.

[44]  M. Hecht,et al.  Small molecule microarrays enable the discovery of compounds that bind the Alzheimer's Aβ peptide and reduce its cytotoxicity. , 2010, Journal of the American Chemical Society.

[45]  D. Vestweber,et al.  Control of endothelial barrier function by regulating vascular endothelial-cadherin , 2010, Current opinion in hematology.

[46]  D. Ehrnhoefer,et al.  EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity , 2010, Proceedings of the National Academy of Sciences.

[47]  Rodrigo Morales,et al.  Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases , 2010, The Journal of Neuroscience.

[48]  P. Vincent,et al.  Src-induced Tyrosine Phosphorylation of VE-cadherin Is Not Sufficient to Decrease Barrier Function of Endothelial Monolayers*♦ , 2010, The Journal of Biological Chemistry.

[49]  A. Korczyn.  The amyloid cascade hypothesis , 2008, Alzheimer's & Dementia.

[50]  T. Berzin,et al.  Microvascular injury and blood–brain barrier leakage in Alzheimer's disease , 2007, Neurobiology of Aging.

[51]  J. Morris,et al.  Fluctuations of CSF amyloid-β levels , 2007, Neurology.

[52]  S. Skaper,et al.  Amyloid β-peptide1–42 alters tight junction protein distribution and expression in brain microvessel endothelial cells , 2006, Neuroscience Letters.

[53]  Jennifer C. Lee,et al.  α-Synuclein: Stable compact and extended monomeric structures and pH dependence of dimer formation , 2004, Journal of the American Society for Mass Spectrometry.

[54]  Elisabetta Dejana,et al.  Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. , 2004, Physiological reviews.

[55]  O. Antzutkin.  Amyloidosis of Alzheimer's Aβ peptides: solid‐state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies , 2004, Magnetic resonance in chemistry : MRC.

[56]  C. Bortner,et al.  Apoptotic volume decrease and the incredible shrinking cell , 2002, Cell Death and Differentiation.

[57]  Makoto Hashimoto,et al.  β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Claudio Soto,et al.  β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.

[59]  M. Mullan,et al.  β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.

[60]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[61]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[62]  Michael R. Schmidt,et al.  Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils. , 2011, Nature chemical biology.

[63]  V. Natarajan,et al.  Vascular Endothelial Barrier Dysfunction Mediated by Amyloid- β Proteins , 2010 .

[64]  Eric E. Smith,et al.  Blood Vessels , and Brain Function , 2009 .

[65]  P. S. St George-Hyslop,et al.  Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. , 2002, Nature medicine.

[66]  D. Butterfield.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. , 2002, Free radical research.

[67]  D. Butterfield,et al.  Vitamin E Prevents Alzheimer's Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production. , 2000, Journal of Alzheimer's disease : JAD.

[68]  H. Mantsch,et al.  The use and misuse of FTIR spectroscopy in the determination of protein structure. , 1995, Critical reviews in biochemistry and molecular biology.